vs

Side-by-side financial comparison of Precipio, Inc. (PRPO) and XWELL, Inc. (XWEL). Click either name above to swap in a different company.

XWELL, Inc. is the larger business by last-quarter revenue ($7.2M vs $6.8M, roughly 1.0× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -129.7%, a 137.4% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -4.2%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-748.0K). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -9.5%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

XWELL, Inc. is a travel wellness and health services provider that primarily operates airport-based wellness locations, offering spa treatments, travel health services including diagnostic testing, and personal care products to leisure and business travelers across major U.S. and international airport hubs.

PRPO vs XWEL — Head-to-Head

Bigger by revenue
XWEL
XWEL
1.0× larger
XWEL
$7.2M
$6.8M
PRPO
Growing faster (revenue YoY)
PRPO
PRPO
+32.6% gap
PRPO
28.4%
-4.2%
XWEL
Higher net margin
PRPO
PRPO
137.4% more per $
PRPO
7.7%
-129.7%
XWEL
More free cash flow
PRPO
PRPO
$1.0M more FCF
PRPO
$291.0K
$-748.0K
XWEL
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-9.5%
XWEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRPO
PRPO
XWEL
XWEL
Revenue
$6.8M
$7.2M
Net Profit
$526.0K
$-9.3M
Gross Margin
45.9%
40.8%
Operating Margin
7.9%
-126.5%
Net Margin
7.7%
-129.7%
Revenue YoY
28.4%
-4.2%
Net Profit YoY
244.1%
-22.2%
EPS (diluted)
$0.36
$-3.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPO
PRPO
XWEL
XWEL
Q4 25
$6.8M
$7.2M
Q3 25
$6.9M
$7.3M
Q2 25
$5.6M
$7.7M
Q1 25
$4.9M
$7.0M
Q4 24
$5.3M
$7.5M
Q3 24
$5.3M
$8.4M
Q2 24
$4.5M
$9.3M
Q1 24
$3.5M
$8.7M
Net Profit
PRPO
PRPO
XWEL
XWEL
Q4 25
$526.0K
$-9.3M
Q3 25
$-79.0K
$-724.0K
Q2 25
$74.0K
$-2.3M
Q1 25
$-884.0K
$-4.7M
Q4 24
$-365.0K
$-7.6M
Q3 24
$-626.0K
$-4.8M
Q2 24
$-1.2M
$-2.0M
Q1 24
$-2.1M
$-2.5M
Gross Margin
PRPO
PRPO
XWEL
XWEL
Q4 25
45.9%
40.8%
Q3 25
43.6%
20.3%
Q2 25
43.2%
23.1%
Q1 25
43.6%
18.8%
Q4 24
49.8%
14.9%
Q3 24
43.1%
24.4%
Q2 24
38.1%
33.2%
Q1 24
26.5%
30.6%
Operating Margin
PRPO
PRPO
XWEL
XWEL
Q4 25
7.9%
-126.5%
Q3 25
-0.9%
-10.5%
Q2 25
-14.6%
-35.0%
Q1 25
-17.5%
-45.0%
Q4 24
-6.3%
-102.7%
Q3 24
-11.3%
-56.6%
Q2 24
-26.8%
-20.4%
Q1 24
-59.6%
-27.3%
Net Margin
PRPO
PRPO
XWEL
XWEL
Q4 25
7.7%
-129.7%
Q3 25
-1.1%
-9.9%
Q2 25
1.3%
-29.5%
Q1 25
-18.0%
-67.2%
Q4 24
-6.9%
-101.7%
Q3 24
-11.9%
-56.4%
Q2 24
-27.1%
-21.5%
Q1 24
-59.8%
-28.8%
EPS (diluted)
PRPO
PRPO
XWEL
XWEL
Q4 25
$0.36
$-3.26
Q3 25
$-0.05
$-0.26
Q2 25
$0.05
$-0.56
Q1 25
$-0.59
$-1.00
Q4 24
$-0.22
$-1.59
Q3 24
$-0.42
$-0.99
Q2 24
$-0.83
$-0.48
Q1 24
$-1.46
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPO
PRPO
XWEL
XWEL
Cash + ST InvestmentsLiquidity on hand
$2.7M
$2.6M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$14.6M
$-22.3M
Total Assets
$21.3M
$11.2M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPO
PRPO
XWEL
XWEL
Q4 25
$2.7M
$2.6M
Q3 25
$2.3M
$4.2M
Q2 25
$1.1M
$8.1M
Q1 25
$1.0M
$11.0M
Q4 24
$1.4M
$11.8M
Q3 24
$1.1M
$16.0M
Q2 24
$1.3M
$18.4M
Q1 24
$776.0K
$19.1M
Total Debt
PRPO
PRPO
XWEL
XWEL
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRPO
PRPO
XWEL
XWEL
Q4 25
$14.6M
$-22.3M
Q3 25
$13.7M
$-6.3M
Q2 25
$12.3M
$-5.2M
Q1 25
$11.7M
$-5.8M
Q4 24
$12.1M
$-788.0K
Q3 24
$11.9M
$6.3M
Q2 24
$12.1M
$8.8M
Q1 24
$12.8M
$10.6M
Total Assets
PRPO
PRPO
XWEL
XWEL
Q4 25
$21.3M
$11.2M
Q3 25
$21.2M
$21.7M
Q2 25
$18.8M
$22.4M
Q1 25
$17.8M
$24.8M
Q4 24
$17.0M
$25.4M
Q3 24
$17.0M
$33.8M
Q2 24
$17.3M
$36.3M
Q1 24
$16.6M
$37.5M
Debt / Equity
PRPO
PRPO
XWEL
XWEL
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPO
PRPO
XWEL
XWEL
Operating Cash FlowLast quarter
$366.0K
$-42.0K
Free Cash FlowOCF − Capex
$291.0K
$-748.0K
FCF MarginFCF / Revenue
4.3%
-10.5%
Capex IntensityCapex / Revenue
1.1%
9.9%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$359.0K
$-11.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPO
PRPO
XWEL
XWEL
Q4 25
$366.0K
$-42.0K
Q3 25
$10.0K
$-2.1M
Q2 25
$353.0K
$-2.4M
Q1 25
$-44.0K
$-4.2M
Q4 24
$565.0K
$-3.5M
Q3 24
$41.0K
$-3.4M
Q2 24
$500.0K
$-443.0K
Q1 24
$-667.0K
$-3.7M
Free Cash Flow
PRPO
PRPO
XWEL
XWEL
Q4 25
$291.0K
$-748.0K
Q3 25
$-44.0K
$-3.1M
Q2 25
$294.0K
$-3.3M
Q1 25
$-182.0K
$-4.6M
Q4 24
$-4.2M
Q3 24
$-68.0K
$-3.8M
Q2 24
$-796.0K
Q1 24
$-4.0M
FCF Margin
PRPO
PRPO
XWEL
XWEL
Q4 25
4.3%
-10.5%
Q3 25
-0.6%
-41.6%
Q2 25
5.2%
-42.6%
Q1 25
-3.7%
-65.5%
Q4 24
-56.2%
Q3 24
-1.3%
-45.4%
Q2 24
-8.6%
Q1 24
-45.5%
Capex Intensity
PRPO
PRPO
XWEL
XWEL
Q4 25
1.1%
9.9%
Q3 25
0.8%
12.9%
Q2 25
1.0%
11.6%
Q1 25
2.8%
6.0%
Q4 24
9.8%
Q3 24
2.1%
4.9%
Q2 24
3.8%
Q1 24
3.3%
Cash Conversion
PRPO
PRPO
XWEL
XWEL
Q4 25
0.70×
Q3 25
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRPO
PRPO

Segment breakdown not available.

XWEL
XWEL

Transferred At Point In Time$5.3M74%
Transferred Over Time$1.9M26%

Related Comparisons